MX9304524A - Nuevos derivados de indol y composiciones que los contienen. - Google Patents

Nuevos derivados de indol y composiciones que los contienen.

Info

Publication number
MX9304524A
MX9304524A MX9304524A MX9304524A MX9304524A MX 9304524 A MX9304524 A MX 9304524A MX 9304524 A MX9304524 A MX 9304524A MX 9304524 A MX9304524 A MX 9304524A MX 9304524 A MX9304524 A MX 9304524A
Authority
MX
Mexico
Prior art keywords
indol
compositions
contain
new derivatives
decarboxylation
Prior art date
Application number
MX9304524A
Other languages
English (en)
Inventor
Armando Vega Noverola
Jacinto Moragues Mauri
Dolors Fernandez Forner
Carles Puig Duran
Jose Prieto Soto
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9304524(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of MX9304524A publication Critical patent/MX9304524A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Abstract

La presente invención describe un compuesto de fórmula (I): 5-so2 ch2(Indol)3 (1-etil alquilamina)c- y las sales farmacéuticamente aceptables de los mismos, los cuales son útiles en el tratamiento de la migraña y otras condiciones. Son preparados por descarboxilación del ácido indolil-2-carboxílico correspondiente.
MX9304524A 1992-07-28 1993-07-27 Nuevos derivados de indol y composiciones que los contienen. MX9304524A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216009A GB9216009D0 (en) 1992-07-28 1992-07-28 New indol derivatives

Publications (1)

Publication Number Publication Date
MX9304524A true MX9304524A (es) 1994-04-29

Family

ID=10719423

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304524A MX9304524A (es) 1992-07-28 1993-07-27 Nuevos derivados de indol y composiciones que los contienen.

Country Status (33)

Country Link
US (1) US5565447A (es)
EP (1) EP0605697B1 (es)
JP (1) JP2716585B2 (es)
KR (1) KR100191830B1 (es)
CN (1) CN1035179C (es)
AT (1) ATE177080T1 (es)
BR (2) BR9305589A (es)
CA (1) CA2120028C (es)
CZ (1) CZ282659B6 (es)
DE (2) DE10199016I2 (es)
DK (1) DK0605697T3 (es)
EC (1) ECSP930953A (es)
EG (1) EG20340A (es)
FI (1) FI109998B (es)
GB (1) GB9216009D0 (es)
GR (1) GR3029915T3 (es)
HK (1) HK1011680A1 (es)
HU (2) HUT70518A (es)
IL (1) IL106387A (es)
LU (1) LU90758I2 (es)
MX (1) MX9304524A (es)
MY (1) MY113266A (es)
NL (1) NL300053I2 (es)
NO (1) NO180231C (es)
NZ (1) NZ254152A (es)
PL (1) PL174352B1 (es)
RU (1) RU2117667C1 (es)
SG (1) SG48708A1 (es)
TW (1) TW235297B (es)
UA (1) UA27818C2 (es)
UY (1) UY23624A1 (es)
WO (1) WO1994002460A1 (es)
ZA (1) ZA935316B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712591B1 (fr) * 1993-11-19 1996-02-09 Pf Medicament Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
FR2731224B1 (fr) * 1995-03-02 1997-05-30 Pf Medicament Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments
GB9523462D0 (en) * 1995-11-16 1996-01-17 Merck Sharp & Dohme Therapeutic agents
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
US6310066B1 (en) 1998-04-29 2001-10-30 American Home Products Corp. Antipsychotic indolyl derivatives
US6066637A (en) * 1998-06-19 2000-05-23 American Home Products Corporation Indolyl derivatives as serotonergic agents
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2006129190A1 (en) * 2005-06-03 2006-12-07 Glenmark Pharmaceuticals Limited Process for the preparation of almotriptan
US20070112055A1 (en) * 2005-09-30 2007-05-17 Glenmark Pharmaceuticals Limited Crystalline forms of almotriptan and processes for their preparation
DE102006027229A1 (de) * 2006-06-09 2007-12-20 Grünenthal GmbH 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
JP2010507585A (ja) * 2006-10-19 2010-03-11 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換インドール
TWI321616B (en) 2007-03-27 2010-03-11 Coretronic Corp Centrifugal blower
CZ302424B6 (cs) * 2007-06-13 2011-05-11 Zentiva, A. S. Zpusob prípravy almotriptanu o vysoké cistote
CA2694608A1 (en) * 2007-08-02 2009-02-05 Generics [Uk] Limited A process for the preparation of almotriptan and a synthetic intermediate usable in said process
CN103724252A (zh) * 2012-10-12 2014-04-16 苏州四同医药科技有限公司 一种阿莫曲坦的制备方法
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB2162532B (en) * 1984-08-04 1988-08-03 Ritchie Swanson John Decontaminant wash composition
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
SK281621B6 (sk) * 1990-06-07 2001-05-10 Astrazeneca Ab Indolové deriváty, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie

Also Published As

Publication number Publication date
PL302917A1 (en) 1994-09-05
DE69323712T2 (de) 1999-07-01
DE69323712D1 (de) 1999-04-08
EP0605697A1 (en) 1994-07-13
CA2120028A1 (en) 1994-02-03
FI941413A (fi) 1994-03-25
NZ254152A (en) 1996-12-20
HU211243A9 (en) 1995-11-28
SG48708A1 (en) 1998-05-18
LU90758I2 (fr) 2001-06-11
NO941019L (no) 1994-03-22
CA2120028C (en) 1999-03-23
CN1087629A (zh) 1994-06-08
DK0605697T3 (da) 1999-09-27
ATE177080T1 (de) 1999-03-15
AU661190B2 (en) 1995-07-13
CZ66494A3 (en) 1994-12-15
FI941413A0 (fi) 1994-03-25
HUT70518A (en) 1995-10-30
JP2716585B2 (ja) 1998-02-18
GB9216009D0 (en) 1992-09-09
EP0605697B1 (en) 1999-03-03
BR9305589A (pt) 1996-01-02
NO180231B (no) 1996-12-02
US5565447A (en) 1996-10-15
NL300053I2 (nl) 2002-04-02
TW235297B (es) 1994-12-01
IL106387A0 (en) 1993-11-15
NO941019D0 (no) 1994-03-22
WO1994002460A1 (en) 1994-02-03
AU4570793A (en) 1994-02-14
NO180231C (no) 1997-03-12
KR100191830B1 (ko) 1999-06-15
NL300053I1 (nl) 2001-11-01
PL174352B1 (pl) 1998-07-31
BR1100061A (pt) 2000-04-18
DE10199016I2 (de) 2006-04-06
CZ282659B6 (cs) 1997-08-13
ZA935316B (en) 1994-02-14
HK1011680A1 (en) 1999-07-16
DE10199016I1 (de) 2001-05-23
JPH06511261A (ja) 1994-12-15
UY23624A1 (es) 1993-08-10
ECSP930953A (es) 1994-08-15
MY113266A (en) 2002-01-31
HU9400869D0 (en) 1994-06-28
UA27818C2 (uk) 2000-10-16
RU2117667C1 (ru) 1998-08-20
FI109998B (fi) 2002-11-15
EG20340A (en) 1998-10-31
IL106387A (en) 1997-04-15
GR3029915T3 (en) 1999-07-30
CN1035179C (zh) 1997-06-18

Similar Documents

Publication Publication Date Title
MX9304524A (es) Nuevos derivados de indol y composiciones que los contienen.
ES2158314T3 (es) Oximas, hidrazonas y olefinas sustituidas como antagonistas de la neuroquinina.
ECSP034744A (es) Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos
ES2097872T3 (es) Fenilpirazolidinonas como agentes broncodilatadores y antiinflamatorios.
UY26872A1 (es) Derivados de la 4- fenil piridina
UY27918A1 (es) Derivados de benzodioxol
SV1998000029A (es) Compuestos de pirazina ref. pg3186
PA8556801A1 (es) Compuestos de imidazopiridin como moduladores de receptor 5-ht 4
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2179353T3 (es) Antagonistas muscarinicos.
AR012426A1 (es) Un compuesto de indazol amida, un procedimiento para prepararlo, compuestos intermediarios, y una composicion farmaceutica que comprende dicho compuesto de indazol amida.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2150039T3 (es) Benzonitrilos como 5-ht agonistas y antagonistas.
PE20040698A1 (es) Derivados de isoindolina
MX9305947A (es) Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
MX9300616A (es) Compuestos antagonistas del receptor 5-hidroxitriptamina, proceso para su prepararcion y composicion farmaceutica que los contiene
AR014964A1 (es) Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones
RU94020400A (ru) Производные индола, способ их получения, фармацевтическая композиция, способ лечения головной боли
ES2159345T3 (es) Indazolcarboxamidas.
ES2124896T3 (es) Amidas del acido ciclohexancarboxilico sustituidas con n-(piperidinil-1-alquilo) como antagonistas de receptores t-ht1a.
PE20021016A1 (es) Conjugados de pregabalina-lactosa
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: ASTRAZENECA UK LIMITED

HC Change of company name or juridical status

Owner name: ASTRAZENECA UK LIMITED